About Keiji AI
Keiji AI builds TrialMind, AI agents for literature review, trial design, trial operations, and analysis. Every output includes its sources, reasoning, and an audit trail.
Our mission: accelerate and improve clinical research with artificial intelligence.
Every number we produce should hold up when a regulator, reviewer, or medical monitor asks how it was produced.
Team leadership
Leadership in the United States and Japan. Engineers and researchers in other locations build and deploy TrialMind with them.
United States
Research & Operations
Jimeng Sun
Professor of Computer Science at UIUC, previously at Georgia Tech. Industry experience at IQVIA and Medidata. Named Top-100 AI Leaders in Drug Discovery and Healthcare.
AI
Brandon Theodorou
BS Harvey Mudd, PhD UIUC. Research experience at the National Institutes of Health (NIH) and IQVIA. Ex-software engineer at ServiceNow, Microsoft. Digital twins and generative models.
Engineering
Venugopal Thati
Ex-VP, Global Head of the platform engineering and enterprise architect at CEVA. Ex-VP Goldman Sachs development of financial services at scale.
Clinical Data Science
Erick Scott
MD (Pittsburgh), MHS (Johns Hopkins). Previously Karius, Kaiser Permanente, and Mount Sinai. Causal inference, real-world evidence, Bayesian modeling, and large language models for clinical analytics.
Japan
AI
Zheng Chen
Associate Professor at Osaka University. Multimodal models, biomedical data science, and AI agents. Leads research, product development, and Japan operations at Keiji AI Japan Branch.
Bioinformatics
Ziwei Yang
PhD, Kyoto University. Research in bioinformatics, metabolic modeling, and multimodal biomedical data, with clinical research and pharmaceutical applications.
AI & Engineering
Xihao Piao
PhD, Osaka University. Research in large language model (LLM) agents and biomedical AI. Builds agentic AI systems for pharmaceutical research, scientific workflows, and enterprise applications.
AI Engineering & Business Development
Hongxi Wang
Leads market development and business initiatives in Japan. Background in construction and data center planning. Focuses on AI agent commercialization and enterprise partnerships.
Company history
Two decades
Research at the University of Illinois
Machine learning research on health data at the University of Illinois Urbana-Champaign (UIUC), published in Nature, Nature Biomedical Engineering, Nature Communications, and leading AI conferences.
From 2020
Clinical trial AI at IQVIA and Medidata
We led clinical trial AI research inside two of the industry's largest platforms and learned where AI is useful in practice.
2023
Keiji AI founded
General-purpose models could write code, but their output was hard for regulated teams to defend. We built agents whose outputs carry citations, traceable logic, and an audit trail.
2026
Branches in India and Japan
We opened a branch in India, followed by a branch in Japan.
Today
In production with customers
In production with pharmaceutical and biotech companies, contract research organizations (CROs), and academic medical centers.
Customers
Pharmaceutical companies, diagnostics companies, and academic medical centers using TrialMind.
